Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHB1300019	左乙拉西坦注射液	levetiracetam	Lyophilized	Chemical Drugs	Supplementary Application	2013-08-19	陕西天森药物研究开发有限公司	Shaanxi Tianshen Pharmaceutical Research and Development Co Ltd	Approval Completed-Pending Certificated	2015-12-14	view
CXHL1200615	左乙拉西坦注射液	levetiracetam	Lyophilized	Chemical Drugs(3.1)	New Drug Application	2013-08-19	陕西天森药物研究开发有限公司	Shaanxi Tianshen Pharmaceutical Research and Development Co Ltd	Certificate Issued	2016-01-14	view
CXHL1100814	丙戊酸半钠缓释片	divalproex sodium	Tablet, extended release	Chemical Drugs(3.1)	New Drug Application	2012-04-27	陕西天森药物研究开发有限公司	Shaanxi Tianshen Pharmaceutical Research and Development Co Ltd	Certificate Issued	2015-08-21	view
CXHL0800435	双丙戊酸钠	divalproex sodium	Active ingredient	Chemical Drugs(3.1)	New Drug Application	2008-11-26	陕西天森药物研究开发有限公司	Shaanxi Tianshen Pharmaceutical Research and Development Co Ltd	Certificate Issued	2010-04-14	view
CXHL0800434	双丙戊酸钠肠溶片	divalproex sodium	Tablet	Chemical Drugs(3.1)	New Drug Application	2008-11-26	陕西天森药物研究开发有限公司	Shaanxi Tianshen Pharmaceutical Research and Development Co Ltd	Certificate Issued	2010-04-01	view